Suchergebnisse - "Palmieri, Salvatore"

PubPharm (7)

1

Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome®) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients

enthalten in: Annals of hematology | 2008

von Camera, A. | Rinaldi, C. | Palmieri, S. | +10

2

Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome®) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients

enthalten in: Annals of hematology | 2008

von Camera, A. | Rinaldi, C. | Palmieri, S. | +10

3

Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome®) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients

enthalten in: Annals of hematology | 2008

von Camera, A. | Rinaldi, C. | Palmieri, S. | +10

4

Clinically useful prognostic factors in acute myeloid leukemia

enthalten in: Critical reviews in oncology/hematology | 2008

von Ferrara, F. | Palmieri, S. | Leoni, F.

5

Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura

enthalten in: Haematologica | 2008

von Zaja, F. | Battista, M. | Pirrotta, M. | +16

CommentIn: Haematologica. 2009 Mar;94(3):443-4; author reply 444-5. - PMID 19252177

6

Clinically useful prognostic factors in acute myeloid leukemia

enthalten in: Critical reviews in oncology, hematology | 2008

von Ferrara, F. | Palmieri, S. | Leoni, F.

7

Platelet Disorders - Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura - In patients with idiopathic thrombocytopenic purpura, low doses of rituximab (100 mg IV weekly for 4 weeks) are effective in correcting thrombocytopenia.

enthalten in: Haematologica, the hematology journal | 2008

von Zaja, F. | Battista, M. | Pirrotta, M. | +16

1
[1]